(Q42659511)

4 November 2017

title

Improved safety with equivalent asthma control in adults with chronic severe asthma on high-dose fluticasone propionate (English)

1 reference

4 November 2017

1 reference

4

1 reference

4 November 2017

N Berend

1

1 reference

4 November 2017

B Kellett

series ordinal

2

1 reference

4 November 2017

N Kent

series ordinal

3

1 reference

4 November 2017

Collaborative Study Group of the Australian Lung Foundation

series ordinal

5

1 reference

4 November 2017

publication date

1 September 2001

1 reference

4 November 2017

1 reference

4 November 2017

volume

6

1 reference

4 November 2017

issue

3

1 reference

4 November 2017

page(s)

237-246

1 reference

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Bone physiology and the osteoporotic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Fluticasone propionate--an update on preclinical and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Relative safety and efficacy of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Characterization of a gamma-carboxyglutamic acid-containing protein from bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Beclomethasone inhalation decreases serum osteocalcin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Bone turnover during high dose inhaled corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Bone turnover during short course prednisolone treatment in patients with chronic obstructive airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2001.00329.X

10.1046/J.1440-1843.2001.00329.X

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference